Feasibility of hyperthermic pressurized intraperitoneal aerosol chemotherapy in a porcine model.

Abstract

Peritoneal carcinomatosis is an unmet therapeutic need. Several types of intraperitoneal chemotherapy have been introduced. However, hyperthermic intraperitoneal chemotherapy has limited drug distribution and poor peritoneal penetration. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) does not have the benefits of hyperthermia. We developed a device to apply hyperthermic PIPAC (H-PAC) and evaluated its feasibility in a porcine model. The device for H-PAC consisted of a laparoscopic aerosol spray and a heater to create hyperthermic capnoperitoneum. We operated on five pigs for the development of the new device and on another five pigs as a survival model. After a pilot experiment of the survival model (Pig A), a hyperthermic pressurized intraperitoneal aerosol of indocyanine green was administered after insertion of three trocars (Pig B) and laparoscopy-assisted distal gastrectomy (LADG) (Pig C) without chemotherapeutic agents. After that, H-PAC with cisplatin was administered after insertion of three trocars (Pig D) and LADG (Pig E). Autopsies were performed on postoperative day 7. Median operation time was 85min (80-110min). Intraperitoneal temperature was constant for 1h of H-PAC (38.8-40.2°C). All five pigs were healthy and survived for 7days. Median weight loss was 0.2kg. Autopsy tissues of stomach, peritoneum, and jejunum were intact in all five pigs. H-PAC was feasible and safe in a porcine model.